论文部分内容阅读
近一年来循环系统领域的研究取得了长足进展。现就其中几个问题予以介绍。一、冠状动脉内血栓纤溶疗法心肌梗塞发病早期选择性地向冠状动脉内注入尿激酶(UK),可使血栓某种程度地溶解。日本冠状动脉血栓溶解研究会对31所医院进行联合调查,在500例急性心肌梗塞病例中,血栓纤溶疗法的冠状动脉再通率为66.8%。发病后2小时内投予尿激酶,用量72万单位以上者效果尤著。目前,围绕血栓纤溶疗法的探讨主要有:
In the past year, great progress has been made in the research of the circulatory system. Here are some of the issues to be introduced. First, coronary fibrinolysis thrombosis myocardial infarction Early onset of selective injection of urokinase (UK) into the coronary artery, can make some degree of thrombosis lysis. Japan’s coronary thrombolysis study will conduct a joint survey of 31 hospitals in 500 cases of acute myocardial infarction, thrombosis fibrinolysis coronary recanalization rate of 66.8%. 2 hours after the onset of urokinase administration, the amount of 720,000 units or more particularly effective. At present, the discussion about thrombus fibrinolysis mainly includes: